Skip to main content

J&J To Pay $344M Over Mesh Lawsuits

J&J To Pay $344M Over Mesh Lawsuits

J&J To Pay $344M Over Mesh Lawsuits

Introduction

Johnson & Johnson (J&J) has to pay $344 million over the lawsuits alleging the company for deceptive marketing of surgical mesh devices for use in pelvic procedures in women, as ordered by a Californian judge.

In 2016, California Attorney General Kamala Harris sued J&J along with its Ethicon unit alleging, the company wrongly marketed the device as being safe for stress urinary incontinence and failed to inform about the serious risks such as chronic pain and sexual dysfunction.

California’s current attorney general, Xavier Becerra, stated that profit was the main motive of J&J over the health of millions of women. The settlement for the lawsuit has brought justice to the women who suffered from the side effects of the device.

The spokesperson for J&J said that the company would appeal the decision as their Ethicon business effectively communicated the risks and benefits of the transvaginal mesh products to doctors and patients. The company even argued that during the 2019 trial, the state failed to prove any miscommunication from Ethicon.

J&J has settled many litigations over the safety of its mesh devices, which also includes an October 2019 agreement to pay $116.9 million to 41 states and the District of Columbia. Currently, J&J faces lawsuits from about 100,000 plaintiffs over the safety and false marketing of a range of products, including opioids and baby powder.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.